X-108666487-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_033380.3(COL4A5):c.3455-9A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 23)
Consequence
COL4A5
NM_033380.3 splice_polypyrimidine_tract, intron
NM_033380.3 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.9483
1
1
Clinical Significance
Conservation
PhyloP100: -1.03
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. Scorers claiming Benign: dbscSNV1_ADA.
PP5
Variant X-108666487-A-G is Pathogenic according to our data. Variant chrX-108666487-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 24633.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-108666487-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A5 | NM_033380.3 | c.3455-9A>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000328300.11 | NP_203699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.3455-9A>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_033380.3 | ENSP00000331902 | ||||
COL4A5 | ENST00000361603.7 | c.3455-9A>G | splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000354505 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2021 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 10862091). This variant has been observed in individual(s) with clinical features of Alport syndrome (PMID: 10862091, Invitae). This variant is also known as 3657-9A>G in the literature. ClinVar contains an entry for this variant (Variation ID: 24633). This variant is not present in population databases (ExAC no frequency). This sequence change falls in intron 38 of the COL4A5 gene. It does not directly change the encoded amino acid sequence of the COL4A5 protein. - |
X-linked Alport syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The COL4A5 c.3455-9A>G variant has been reported in hemizygous state in individuals affected with Alport syndrome (Martin P et al.). Experimental studies have shown that this variant disrupts mRNA splicing (Martin P et al). The variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic. This sequence change falls in intron 38 of the COL4A5 gene. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at